Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.
about
Anatomical and molecular imaging of skin cancerReceptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the LigandMalignant melanoma and melanocortin 1 receptor.Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptideReduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptakeTargeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analoguesGallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides.Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptakePeptide-targeted radionuclide therapy for melanoma.Synthesis and bioactivity of MSH4 oligomers prepared by an A2 + B2 strategy.Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles.Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanomaMelanin as a potential target for radionuclide therapy of metastatic melanoma.Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptideMelanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.Evaluation of new Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides for melanoma imaging.Effects of amino acids on melanoma targeting and clearance properties of Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides.Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.Radiometallated peptides for molecular imaging and targeted therapy.Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.Imaging human melanoma using a novel Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptide.Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptideSubstitution of Gly with Ala enhanced the melanoma uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imagingPeptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach.Linker modification reduced the renal uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.Metastatic melanoma imaging using a novel Tc-99m-labeled lactam-cyclized alpha-MSH peptide.Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.
P2860
Q30476227-8136C17E-F767-4865-97CC-A4261059F6D9Q33603269-327A52B8-221D-4915-8473-FB38958B00EEQ33782773-6210C793-F7B9-4912-9897-C58EDC129B91Q34165263-D0689998-09BB-471C-8253-191A6ABE2DE0Q34386219-7FED4A0C-1CD2-40BF-8585-A739E1836B35Q34395062-504418C7-86C7-41F4-90C3-5F511543505EQ34436663-FCFEFAA3-12EC-4137-8511-9FEEB25C13F0Q34525161-FCF5A397-EFCC-4791-B15E-629CB534D42CQ34728904-1EA6915A-83BC-4229-97DD-0CD548CF3F37Q35187053-57C8A5E5-A3A2-4B75-9631-964C4F6EFEB6Q35393994-945FC7CF-52DC-4469-BEED-BEA71656FC98Q35781719-BE8A6ECC-D918-44BD-B82E-EFE29480B5E5Q35947223-56D593A9-EC04-47F0-AFAD-965F53002056Q35972603-96C90266-3D14-4015-9A85-1F9B478D6CB4Q36230221-46899BA7-F38B-42B4-AA7D-DD830F4C79BEQ36346633-DA657B3B-D181-4142-BCBE-E58DD2FE4829Q36429546-BEED9F4C-6D50-407F-8A96-9A9B07BCDE65Q36476200-79277800-3D2C-4DF0-B8E3-80FC6AA95B32Q36580750-9515E9D8-1109-436D-94DD-5C0AF06FA232Q36737564-EAD09B4D-38B0-4ED0-A85C-10D6BAF7E182Q36743097-FF1DF82D-AC20-40C8-AA9B-BE69A59F4B19Q36753402-E10EE7A0-FFC7-4CD0-8092-2DABE1988931Q37199680-722455FD-7E66-4380-A773-2568FD19F03BQ37364790-04DBB86C-2CA6-4578-AF5D-260FCEA574BFQ37399483-97BFC163-8E8A-44E2-9E06-69A3B19E286EQ37432511-154FCD26-F33D-42E2-AA01-3A8F67AA9450Q37450632-6B8D357B-2850-4823-A320-D01E71669CE6Q37515861-7CAB116F-E41C-4F6B-A93E-C0AEB06F4AF3Q37847064-D591E478-F8B0-4DBE-A387-2AA199261E25Q38382330-25A67586-5155-4DB3-8765-58AE37881637Q38749672-4E89529B-9467-4074-8D47-C0F69E100AE7Q39183267-0532B017-A5BD-4855-A61D-4740B6CED33EQ39403093-0F2A6812-48F0-497E-8915-E38545D8B496Q39635152-861F1AF2-842A-4E56-9471-AE4B8DE719B2Q41849071-5D195917-AFA7-4139-B121-85E6C6BF40B4Q41866914-659DA202-D608-4029-A43D-4AF851B12589Q47135383-ABCA441D-4825-4D9B-BF6F-26940EC973D1Q47425177-9314D176-C6AA-4B59-9117-0B2B98383BD9Q47731673-69F1B733-0095-4BE1-84F1-CE96B1987F41
P2860
Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Evaluation of the human melano ...... ing hormone peptide analogues.
@en
type
label
Evaluation of the human melano ...... ing hormone peptide analogues.
@en
prefLabel
Evaluation of the human melano ...... ing hormone peptide analogues.
@en
P2093
P356
P1476
Evaluation of the human melano ...... ing hormone peptide analogues.
@en
P2093
Donna Whitener
Jianqing Chen
Nellie K Owen
Thomas P Quinn
Weiwei Feng
Yubin Miao
P304
P356
10.1021/BC034069I
P577
2003-11-01T00:00:00Z